The Partnership for Health System Sustainability and Resilience (PHSSR) held its 3rd Summit on 14 May 2024 during Abu Dhabi Global Healthcare Week, an event hosted by the Department of Health Abu Dhabi (DOH) that attracted thousands of healthcare stakeholders from around the world.
Michel Demaré, Chair of the Board, AstraZeneca, provided welcoming remarks, followed by an engaging opening address from H.E. Mansoor Ibrahim Al Mansoori, Chairman, DOH, outlining Abu Dhabi’s role in strengthening global health systems and championing the importance of multi-sector collaboration and PHSSR research in the region.
The Ministers of Health of Egypt and Greece gave keynote speeches, highlighting the importance of working together via international partnerships, such as PHSSR, to bolster the sustainability and resilience of health systems around the world.
Professor Elias Mossialos, Brian Abel-Smith Professor of Health Policy at the London School of Economics (LSE) and Director of LSE Health, spoke about the need to build “learning health systems” and facilitate strong, international connections between researchers working in the field via initiatives such as PHSSR.
There was great excitement for the launch of the Abu Dhabi PHSSR report, with key findings shared by H.E. Dr. Ahmed Al Khazraji, Acting Director General, Abu Dhabi Public Health Centre (ADPHC), followed by a panel discussion delving into the implications for the Abu Dhabi health system.
Abu Dhabi is a leading example of the rapidly evolving healthcare landscape in the Middle East and globally. The emirate has expanded its health sector, providing residents and visitors access to a broad range of healthcare services, including primary care, emergency care and advanced genomics. The introduction of mandatory health insurance for all residents in 2006 aims to ensure universal healthcare access for its population. Local health care regulators and stakeholders are also proactively expanding adoption and accessibility of digital technologies, health services and innovative technologies, such as artificial intelligence (AI). This report – developed in close collaboration with the DOH – provides insights into the local health system, including recommendations on strengthening its sustainability and resilience.
The Abu Dhabi PHSSR report will be available on the website soon.
The second session, moderated by PHSSR Steering Committee member Jan-Willem Scheijgrond, Vice President, Global Head of Government and Public Affairs, Philips, emphasised the urgent need for action on non-communicable diseases (NCDs), including developments in digital health and AI as key enablers of progress in this space. George Wharton, Associate Professor, Department of Health Policy, LSE, underscored the need to transition from “sick care” to “health care”, outlining that NCDs will be the first area of focus for the upcoming PHSSR Policy Roadmap series.
The session concluded with two panel discussions exploring the role of digital technology in acting early on NCDs, and investing in preventative care.
Visit the LSE Consulting Blog to learn more about the growing prevalence of NCDs, the importance of acting early to tackle them, and the potential for data and digital healthcare technologies to support comprehensive and personalised approaches to early detection and intervention.
The third session, moderated by PHSSR Steering Committee member Anna van Poucke, Global Head of Healthcare, KPMG International, focused on the reciprocal relationship between climate and health. H.E. Dr. Jean Kaseya, Director General of Africa Centres for Disease Control and Prevention, delivered a keynote speech on how demographic and climate changes already impact African health systems and the urgent need for regional and national action to address these challenges.
The session concluded with two panel discussions on the impact of climate on health equity, and practical steps towards implementing environmental policies.
Tune in to the Abu Dhabi Global Healthcare Week ‘HealthBeats’ podcast to hear from Stefan Weber, Vice President, Head of Global Policy, Advocacy and Health Equity, AstraZeneca, on how initiatives like PHSSR are working to decarbonise healthcare and support a healthier future for people and communities around the world.
Delivering closing remarks, PHSSR Steering Committee member Iskra Reic, Executive Vice President, Vaccines & Immune Therapies, AstraZeneca, reflected on the critical importance of bringing policymakers, experts, and stakeholders together during events like the PHSSR 3rd Summit and Abu Dhabi Global Healthcare Week, to ensure health systems can effectively serve people and communities worldwide, both now and in the future.
Many thanks to all those who shared their knowledge and expertise during this important event:
Participating PHSSR Steering Committee members: